Chemtura beats estimates, but bromine weakness persists

21:49 PM | July 30, 2013 | Vincent Valk

Chemtura's second-quarter net income from continuing declined 11% year-on-year (YOY), to $47 million, or 47 cts/share, on sales down 1%, to $735 million, the company says. Adjusted net income declined...